Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Q&A: ACC President Edward Fry discusses the past, present & future of cardiology | CV mortality & dialysis
Tuesday, April 19, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Q&A: New ACC President Edward Fry discusses the past, present and future of cardiology

Fry joined us for an exclusive interview, discussing lessons learned during the pandemic, some key ways to address physician burnout and much more. 

READ MORE >
Edward Fry, MD, is the 2022-23 ACC president.
Share on Twitter Share on Facebook Share on Linkedin

Q&A: New ACC President Edward Fry discusses the past, present and future of cardiology

Share on Twitter Share on Facebook Share on Linkedin
Edward Fry, MD, is the 2022-23 ACC president.
Fry joined us for an exclusive interview, discussing lessons learned during the pandemic, some key ways to address physician burnout and much more. 
READ MORE >

Deaths from MI, stroke and pulmonary embolism are down among kidney patients receiving dialysis

The new analysis, published in JAMA Network Open, focused on more than 220,000 dialysis patients treated from 1998 to 2015. 

READ MORE >
A renal failure patient receives dialysis. A new study shows a drop in death in kidney failure patients from heart attack, PE and stroke.
Share on Twitter Share on Facebook Share on Linkedin

Deaths from MI, stroke and pulmonary embolism are down among kidney patients receiving dialysis

Share on Twitter Share on Facebook Share on Linkedin
A renal failure patient receives dialysis. A new study shows a drop in death in kidney failure patients from heart attack, PE and stroke.
The new analysis, published in JAMA Network Open, focused on more than 220,000 dialysis patients treated from 1998 to 2015. 
READ MORE >

Featured Articles

Cardiology’s average salary climbs to $490k, No. 3 among all specialties

This continues a consistent rise in pay for the specialty—the same report recorded cardiology’s average salary as $459,000 in 2021, $438,000 in 2020 and $430,000 in 2019.

READ MORE >
Cardiologist heart
Share on Twitter Share on Facebook Share on Linkedin

Cardiology’s average salary climbs to $490k, No. 3 among all specialties

Share on Twitter Share on Facebook Share on Linkedin
Cardiologist heart
This continues a consistent rise in pay for the specialty—the same report recorded cardiology’s average salary as $459,000 in 2021, $438,000 in 2020 and $430,000 in 2019.
READ MORE >

American Heart Association awards $10.6M to researchers investigating the long-term cardiovascular effects of COVID-19

The grants went to 11 different research teams in the United States and are expected to fund these projects for three years.

READ MORE >
The AHA is granting more money toward research on the cardIovascular effects of COVID-19. #COVIS #COVID19 #SARSCoV2 #longCOVID
Share on Twitter Share on Facebook Share on Linkedin

American Heart Association awards $10.6M to researchers investigating the long-term cardiovascular effects of COVID-19

Share on Twitter Share on Facebook Share on Linkedin
The AHA is granting more money toward research on the cardIovascular effects of COVID-19. #COVIS #COVID19 #SARSCoV2 #longCOVID
The grants went to 11 different research teams in the United States and are expected to fund these projects for three years.
READ MORE >

In Case You Missed It

Renal denervation linked to significant blood pressure reductions after 3 years

An updated look at patients treated with Medtronic's renal denervation system was presented at ACC.22 and simultaneously published in The Lancet. 

READ MORE >
The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.
Share on Twitter Share on Facebook Share on Linkedin

Renal denervation linked to significant blood pressure reductions after 3 years

Share on Twitter Share on Facebook Share on Linkedin
The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.
An updated look at patients treated with Medtronic's renal denervation system was presented at ACC.22 and simultaneously published in The Lancet. 
READ MORE >

VIDEO: Use of mRNA drug to lower lipoprotein(a) by up to 98%

Steven E. Nissen, MD, chief academic officer of the Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute at the Cleveland Clinic, was the lead author on the Apollo Trial, a late-breaking ACC.22 study evaluating the effectiveness of an mRNA drug to suppress lipoprotein(a).

READ MORE >
Steven Nissen, MD, Cleveland Clinic, explains an ACC.22 late-breaking trials that uses an mRNA drug to greatly reduce lipoprotein A. #ACC22
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Use of mRNA drug to lower lipoprotein(a) by up to 98%

Share on Twitter Share on Facebook Share on Linkedin
Steven Nissen, MD, Cleveland Clinic, explains an ACC.22 late-breaking trials that uses an mRNA drug to greatly reduce lipoprotein A. #ACC22
Steven E. Nissen, MD, chief academic officer of the Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute at the Cleveland Clinic, was the lead author on the Apollo Trial, a late-breaking ACC.22 study evaluating the effectiveness of an mRNA drug to suppress lipoprotein(a).
READ MORE >

In Other News

American Society of Nuclear Cardiology urges Congress to speed prior authorizations, repeal AUC mandate 

Over the past few weeks, members of ASNC’s Health Policy Committee have held meetings with their members of Congress.

READ MORE >
The ASNC is one of several medical imaging societies asking Congress to repeal the appropriate use criteria (AUC) criteria mandate. They say it poses issues for clinicians and is becoming outdated by changes in CMS payment systems. The AUC requirements call for documentation using CVMS authorized software in order to show advanced imaging such as nuclear and CT is justified, or else Medicare payments might be withheld.
Share on Twitter Share on Facebook Share on Linkedin

American Society of Nuclear Cardiology urges Congress to speed prior authorizations, repeal AUC mandate 

Share on Twitter Share on Facebook Share on Linkedin
The ASNC is one of several medical imaging societies asking Congress to repeal the appropriate use criteria (AUC) criteria mandate. They say it poses issues for clinicians and is becoming outdated by changes in CMS payment systems. The AUC requirements call for documentation using CVMS authorized software in order to show advanced imaging such as nuclear and CT is justified, or else Medicare payments might be withheld.
Over the past few weeks, members of ASNC’s Health Policy Committee have held meetings with their members of Congress.
READ MORE >

6 ways healthcare organizations can help the disruptive radiologist

Radiologists, like all other people, can sometimes react to difficult situations with disruptive behavior.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

6 ways healthcare organizations can help the disruptive radiologist

Share on Twitter Share on Facebook Share on Linkedin
Radiologists, like all other people, can sometimes react to difficult situations with disruptive behavior.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme